PubRank

N Aronin

Author PubWeight™ 72.50‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 1997 11.53
2 Huntingtin expression stimulates endosomal-lysosomal activity, endosome tubulation, and autophagy. J Neurosci 2000 3.16
3 Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits. Proc Natl Acad Sci U S A 2007 3.07
4 Early and progressive accumulation of reactive microglia in the Huntington disease brain. J Neuropathol Exp Neurol 2001 2.17
5 Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. Ann Intern Med 1984 2.01
6 Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis. Proc Natl Acad Sci U S A 2001 1.99
7 Wild-type and mutant huntingtins function in vesicle trafficking in the secretory and endocytic pathways. Exp Neurol 1998 1.85
8 Huntingtin localization in brains of normal and Huntington's disease patients. Ann Neurol 1997 1.82
9 Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease. J Neurosci 2001 1.52
10 Coordinate occupancy of AP-1 sites in the vitamin D-responsive and CCAAT box elements by Fos-Jun in the osteocalcin gene: model for phenotype suppression of transcription. Proc Natl Acad Sci U S A 1990 1.41
11 Mutant huntingtin expression in clonal striatal cells: dissociation of inclusion formation and neuronal survival by caspase inhibition. J Neurosci 1999 1.40
12 Immunohistochemical localization of the D1 dopamine receptor in rat brain reveals its axonal transport, pre- and postsynaptic localization, and prevalence in the basal ganglia, limbic system, and thalamic reticular nucleus. Proc Natl Acad Sci U S A 1992 1.27
13 Expression of normal and mutant huntingtin in the developing brain. J Neurosci 1996 1.21
14 Fast transport and retrograde movement of huntingtin and HAP 1 in axons. Neuroreport 1997 1.20
15 Are neuronal intranuclear inclusions the common neuropathology of triplet-repeat disorders with polyglutamine-repeat expansions? Lancet 1998 1.17
16 Pro-caspase-8 is predominantly localized in mitochondria and released into cytoplasm upon apoptotic stimulation. J Biol Chem 2000 1.15
17 Axonal transport of N-terminal huntingtin suggests early pathology of corticostriatal projections in Huntington disease. J Neuropathol Exp Neurol 1999 1.10
18 Analysis of Huntingtin-associated protein 1 in mouse brain and immortalized striatal neurons. J Comp Neurol 1999 1.07
19 Differential regulation of fos family genes in the ventrolateral and dorsomedial subdivisions of the rat suprachiasmatic nucleus. Neuroscience 2000 1.05
20 Localization of immunoreactive enkephalins in GABA synthesizing neurons of the rat neostriatum. Brain Res 1984 1.03
21 Light and electron microscopic localization of immunoreactive Leu-enkephalin in the monkey basal ganglia. J Neurosci 1982 0.99
22 Colocalization of D1 and D2 dopamine receptor mRNAs in striatal neurons. Brain Res 1993 0.96
23 Forskolin and dopamine D1 receptor activation increase huntingtin's association with endosomes in immortalized neuronal cells of striatal origin. Neuroscience 1999 0.90
24 Ultrastructural features of immunoreactive somatostatin neurons in the rat caudate nucleus. J Neurosci 1982 0.89
25 A kindred with a variant of multiple endocrine neoplasia type 1 demonstrating frequent expression of pituitary tumors but not linked to the multiple endocrine neoplasia type 1 locus at chromosome region 11q13. J Clin Endocrinol Metab 1997 0.89
26 Functional role for Sp1 in the transcriptional amplification of a cell cycle regulated histone H4 gene. Biochemistry 1995 0.87
27 Sustained remission of Nelson's syndrome after stopping cyproheptadine treatment. N Engl J Med 1980 0.87
28 Ultrastructural localization of immunoreactive calbindin-D28k in the rat and monkey basal ganglia, including subcellular distribution with colloidal gold labeling. J Comp Neurol 1989 0.86
29 Maintenance of susceptibility to neurodegeneration following intrastriatal injections of quinolinic acid in a new transgenic mouse model of Huntington's disease. Exp Neurol 2002 0.86
30 Substance P and neurotensin: their roles in the regulation of anterior pituitary function. Annu Rev Physiol 1986 0.84
31 The distribution of substance P-containing neurons in the cat Edinger-Westphal nucleus: relationship to efferent projection systems. Brain Res 1983 0.84
32 Does capsaicin relieve the pain of diabetic neuropathy? Pain 1990 0.84
33 Fluorescent and biotin probes for dopamine receptors: D1 and D2 receptor affinity and selectivity. Mol Pharmacol 1990 0.83
34 Temporal regulation of light-induced Fos and Fos-like protein expression in the ventrolateral subdivision of the rat suprachiasmatic nucleus. Neuroscience 1994 0.82
35 Substance P and neurotensin. Recent Prog Horm Res 1982 0.81
36 Compositional changes of AP-1 DNA-binding proteins are regulated by light in a mammalian circadian clock. Neuron 1993 0.80
37 Monoamines in the brain cerebrospinal fluid of facial pain patients. Anesth Prog 1992 0.80
38 Downregulation of histone H4 gene transcription during postnatal development in transgenic mice and at the onset of differentiation in transgenically derived calvarial osteoblast cultures. J Cell Biochem 1992 0.80
39 Ultrastructural localization and biochemical features of immunoreactive LEU-enkephalin in monkey dorsal horn. J Neurosci 1981 0.79
40 Prognostic differences in subgroups of patients with electrographic evidence of subendocardial or transmural myocardial infarction. The favorable outlook for patients with an initially normal QRS complex. Am J Med 1980 0.79
41 The stability and metabolism of intravenously administered neurotensin in the rat. Peptides 1982 0.78
42 Frequency of painless myocardial ischemia during exercise tolerance testing in patients with and without diabetes mellitus. Am J Cardiol 1987 0.78
43 Comparative metabolic clearance rates of beta-endorphin and beta-lipotropin in humans. Life Sci 1981 0.78
44 The differential effects of thyroid and gonadal hormones on substance P content in the anterior pituitary of the prepubertal rat. Endocrinology 1985 0.78
45 c-Fos expression in the rat intergeniculate leaflet: photic regulation, co-localization with Fos-B, and cellular identification. Brain Res 1996 0.78
46 Plasma immunoreactive beta-endorphin is elevated in uraemia. Clin Endocrinol (Oxf) 1983 0.77
47 Immunohistochemical evidence for neural mediation of VIP activity in the dogfish rectal gland. Peptides 1988 0.77
48 Regulation by thyroid hormone of the concentration of substance P in the rat anterior pituitary. Endocrinology 1984 0.77
49 Unexpected c-fos gene expression in the suprachiasmatic nucleus of mice entrained to a skeleton photoperiod. J Biol Rhythms 1996 0.77
50 Somatostatin is increased in the basal ganglia in Huntington disease. Ann Neurol 1983 0.77
51 In vitro stimulation of c-Fos protein expression in the suprachiasmatic nucleus of hypothalamic slices. Brain Res Mol Brain Res 1996 0.77
52 Diabetes mellitus and silent myocardial ischemia. Adv Cardiol 1990 0.76
53 A Golgi study of the monkey paraventricular nucleus: neuronal types, afferent and efferent fibers. J Comp Neurol 1987 0.76
54 Synaptic interactions between GABAergic neurons and trigeminothalamic cells in the rat trigeminal nucleus caudalis. Synapse 1990 0.76
55 Immunoreactive leu-enkephalin in the monkey hypothalamus including observations on its ultrastructural localization in the paraventricular nucleus. J Comp Neurol 1984 0.76
56 Dde-I restriction endonuclease fragmentation: a novel method of generating cDNA probes for in situ hybridization in brain. J Histochem Cytochem 1997 0.76
57 The effects of gonadal steroids on the content of substance P in the rat anterior pituitary. Endocrinology 1984 0.76
58 The myopathy of Cushing's syndrome. Muscle Nerve 1993 0.75
59 Ultrastructural localization of immunoreactive neurotensin in the monkey superficial dorsal horn. J Comp Neurol 1984 0.75
60 Impaired clearance of beta-lipotropin in uremia. J Clin Endocrinol Metab 1981 0.75
61 Metastatic papillary thyroid carcinoma to lung diagnosed by bronchoalveolar lavage. J Clin Endocrinol Metab 1996 0.75
62 Circadian regulation of Fos B is different from c-Fos in the rat suprachiasmatic nucleus. Brain Res Mol Brain Res 1994 0.75
63 Light microscopic and ultrastructural localization of immunoreactive substance P in the dorsal horn of monkey spinal cord. Neuroscience 1982 0.75
64 Immunoreactive substance P in the substantia nigra of the monkey: light and electron microscopic localization. Brain Res 1982 0.75
65 Glutamic acid decarboxylase and enkephalin immunoreactive axon terminals in the rat neostriatum synapse with striatonigral neurons. Brain Res 1986 0.75
66 Quantitative electron microscopic study of immunoreactive somatostatin axons in the rat neostriatum. Neurosci Lett 1984 0.75
67 Transient myocardial perfusion abnormalities in diabetic patients: a prospective study using thallium exercise tolerance testing. Cardiology 1991 0.75
68 Failure of bromocriptine to lower plasma catecholamines in normal men and women. J Clin Endocrinol Metab 1982 0.75